Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenneth Hillan Insider Profile
11 Followers
Kenneth Hillan, President of Achaogen and President of R&D, Director at Achaogen, holds 293.34K shares in Achaogen (Ticker: AKAOQ), holds ― shares in Zymeworks (Ticker: ZYME), holds 221.88K shares in 23andMe Holding (Ticker: ME). Most recently, Kenneth Hillan Bought ― shares of Achaogen on Jun 29, 2018 for an estimated value of 1.08M.
Kenneth Hillan Achaogen (AKAOQ)President of Achaogen and President of R&D, Director
Achaogen (AKAOQ)
President of Achaogen and President of R&D, Director
Ranked #93,044 out of 98,501 Corporate Insiders
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
-59.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kenneth Hillan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kenneth Hillan
Kenneth Hillan's Trading History
Achaogen
Jun 29, 2018
―
Informative Buy
1.08M
$7.33K
Zymeworks
―
Director
―
―
Sangamo Biosciences
Jun 05, 2023
Director
Uninformative Buy
―
$25.59K
23andMe Holding
Jun 07, 2023
Chief Therapeutics Officer
Uninformative Buy
―
$78.99K
Relypsa Inc
Jun 23, 2016
―
Uninformative Buy
―
$71.98K
List of latest transactions for each holding click on a transaction to see Kenneth Hillan's performance on stock
You May Also Like
Kenneth Hillan insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Hillan?
The percentage of profitable transactions made by Kenneth Hillan is 80%.
What is the average return per transaction made by Kenneth Hillan?
The average return per transaction made by Kenneth Hillan is -59.60%.
What stocks does Kenneth Hillan hold?
Kenneth Hillan holds: AKAOQ, ZYME, SGMO, ME, RLYP stocks.
What was Kenneth Hillan’s latest transaction?
Kenneth Hillan latest transaction was an Informative Buy of $1.08M.
What was Kenneth Hillan's most profitable transaction?
Kenneth Hillan’s most profitable transaction was an Informative Sell of ME stock on August 25, 2022. The return on the trade was 71.20%.
What is Kenneth Hillan's role in Achaogen?
Kenneth Hillan's role in Achaogen is President of Achaogen and President of R&D, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.